|
UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (USD $)
In Thousands, except Per Share data, unless otherwise specified |
3 Months Ended | |
|---|---|---|
|
Mar. 31, 2015
|
Mar. 31, 2014
|
|
| Income Statement [Abstract] | ||
| Net revenue | $ 35,396us-gaap_SalesRevenueNet | $ 32,501us-gaap_SalesRevenueNet |
| Cost of net revenue | 13,725us-gaap_CostOfRevenue | 12,448us-gaap_CostOfRevenue |
| Gross profit | 21,671us-gaap_GrossProfit | 20,053us-gaap_GrossProfit |
| Operating expenses: | ||
| Research and development | 15,281us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost | 13,095us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost |
| Selling, general and administrative | 10,944us-gaap_SellingGeneralAndAdministrativeExpense | 7,761us-gaap_SellingGeneralAndAdministrativeExpense |
| Total operating expenses | 26,225us-gaap_OperatingExpenses | 20,856us-gaap_OperatingExpenses |
| Loss from operations | (4,554)us-gaap_OperatingIncomeLoss | (803)us-gaap_OperatingIncomeLoss |
| Interest income | 70us-gaap_InvestmentIncomeInterest | 61us-gaap_InvestmentIncomeInterest |
| Interest expense | 0us-gaap_InterestExpense | 0us-gaap_InterestExpense |
| Other expense, net | (34)us-gaap_OtherNonoperatingIncomeExpense | (12)us-gaap_OtherNonoperatingIncomeExpense |
| Loss before provision for income taxes | (4,518)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments | (754)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments |
| Provision for income taxes | 204us-gaap_IncomeTaxExpenseBenefit | 108us-gaap_IncomeTaxExpenseBenefit |
| Net loss | $ (4,722)us-gaap_NetIncomeLoss | $ (862)us-gaap_NetIncomeLoss |
| Net loss per share: | ||
| Basic (usd per share) | $ (0.12)us-gaap_EarningsPerShareBasic | $ (0.02)us-gaap_EarningsPerShareBasic |
| Diluted (usd per share) | $ (0.12)us-gaap_EarningsPerShareDiluted | $ (0.02)us-gaap_EarningsPerShareDiluted |
| Shares used to compute net loss per share: | ||
| Basic (shares) | 38,015us-gaap_WeightedAverageNumberOfSharesOutstandingBasic | 35,369us-gaap_WeightedAverageNumberOfSharesOutstandingBasic |
| Diluted (shares) | 38,015us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding | 35,369us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding |
| X | ||||||||||
|
- Definition
The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Sum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
|
- Definition
The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|